Loading...
Market
Area of medicine most impacted by discovery of extra organs by 2025?
2
Resolution / Starting Odds
Obstetrics and Gynecology • 25%
Urology • 25%
Genetics • 25%
Other • 25%
Medical journals, research studies, or official announcements
Story
Australian Woman's Severe Pain Reveals Five Extra Organs in Shocking Medical Discovery
Oct 26, 2024, 01:00 PM
A 21-year-old Australian woman, who had been suffering from severe stomach pain for years, underwent exploratory surgery after tests failed to reveal the source of her infections. Doctors initially suspected a tumor but were shocked to find that the mass was actually an abscess caused by actinomycosis bacteria and a staph infection. Additionally, they discovered that she had five extra organs, including two uteruses, four ovaries, two cervixes, and three kidneys. The woman suspects she may have been a twin, and the extra organs could be remnants of her twin. She described the terrifying consequence of ignoring her tummy troubles, stating, 'I heard a pop... and my insides fell out.'
View original story
Similar markets
Cardiovascular System • 25%
Hormonal System • 25%
Respiratory System • 25%
Other • 25%
Neurology • 25%
Dermatology • 25%
Pain management • 25%
Other • 25%
Cancer treatment • 25%
Neurodegenerative disease treatment • 25%
Infectious disease treatment • 25%
Other • 25%
Orthopedic surgery • 25%
Cardiovascular surgery • 25%
Neurosurgery • 25%
General surgery • 25%
Liver • 25%
Kidneys • 25%
Lungs • 25%
Heart • 25%
Diagnostics • 25%
Patient Monitoring • 25%
Administrative Tasks • 25%
Treatment Recommendations • 25%
Brain (other than olfactory bulb) • 25%
Kidneys • 25%
Pancreas • 25%
Other • 25%
Early skin cancer detection • 25%
Locating injuries • 25%
Tumor detection • 25%
Other • 25%
Gender-affirming therapies • 25%
Immune response studies • 25%
Sex differences in disease susceptibility • 25%
Other • 25%
Early skin cancer detection • 25%
Blood flow monitoring • 25%
Digestive system observation • 25%
Other • 25%
Bone • 25%
Muscle • 25%
Lung • 25%
Other • 25%
Revivicor • 25%
eGenesis • 25%
United Therapeutics • 25%
Other • 25%